The Use of Sugammadex in the Critically Ill

NCT03791801 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Critical Illness

Interventions

DRUG: Sugammadex
DRUG: Neostigmine
DRUG: Rocuronium
DRUG: Glycopyrrolate

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre